Magnifiq Pharma Private Limited
About Magnifiq Pharma Private Limited
Data last updated:
Magnifiq Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 04 July 2023.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U21001TS2023PTC174599.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Parvatham Anjamma and Venkat Sainadh Reddy Parvatham.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.22 Lakh, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹50,253 (net margin 2.2%) and EBITDA of ₹7.24 Lakh (EBITDA margin 31.2%).
As per MCA filings, the company has open charges of ₹1 Cr on record.
Company details
Contact details
Magnifiq Pharma Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressFlat 704 Block F Vertex Sadguru Krupa Apartments Bridavan Colony, Nizampet X Road, Hyderabad, Telangana, India – 500072
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Magnifiq Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Magnifiq Pharma Private Limited, buy the company report.
Financials of Magnifiq Pharma Private Limited
FY 2025 filings availableMagnifiq Pharma Private Limited reported revenue of ₹23.22 Lakh (up 26% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 26% in the latest year. EBITDA rose 951% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹7.24 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹50,253 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 31.2% | |
| Net Profit Margin | 2.2% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Magnifiq Pharma Private Limited, buy the company report.
Board of directors of Magnifiq Pharma Private Limited
Magnifiq Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Parvatham Anjamma | Director | 04 Jul 2023 | 3 Years 4 Months | Current |
| Venkat Sainadh Reddy Parvatham | Director | 04 Jul 2023 | 3 Years 4 Months | Current |
| Hari Hara Satish Kancharla | Director | 14 Aug 2025 | 1 Years 2 Months | Current |
Peer comparison
Magnifiq Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| G. A. Exports Private Limited | ₹23.25 Lakh (FY 2016) | 57.0% | New Delhi, Delhi, India | |||
| Worels Pharma Private Limited | ₹23.25 Lakh (FY 2024) | -53.0% | Hyderabad, Telangana, India | |||
| Kar Auto Private Limited | ₹23.24 Lakh (FY 2025) | 6.0% | Ddy, Telangana, India | |||
| Velisca Healthcare Private Limited | ₹23.23 Lakh (FY 2022) | 165.0% | Mumbai, Maharashtra, India | |||
| Maxaroma Private Limited | ₹23.23 Lakh (FY 2025) | -28.0% | Punjab, India | |||
| Magnifiq Pharma Private Limitedthis company | ₹23.22 Lakh (FY 2025) | ₹50,253 | 2.2% | 26.0% | Hyderabad, Telangana, India | |
| Sumangal Collection Private Limited | ₹23.22 Lakh (FY 2023) | 21.0% | Kolkata, West Bengal, India | |||
| 5 Rivers Traders Private Limited | ₹23.21 Lakh (FY 2024) | -31.0% | Rajpura, Punjab, India | |||
| Gatral Health Care Private Limited | ₹23.21 Lakh (FY 2024) | 3751.0% | Jamnagar, Gujarat, India | |||
| MP Autovehicles Private Limited | ₹23.21 Lakh (FY 2025) | 22.0% | Varanasi, Uttar Pradesh, India | |||
| Sunbeat Power System Private Limited | ₹23.21 Lakh (FY 2022) | Jaipur, Rajasthan, India |
To see the full peer comparison of Magnifiq Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Nov 2023 | 100827030 | Others | ₹1 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Magnifiq Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Magnifiq Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Magnifiq Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Magnifiq Pharma Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Hari Hara Satish Kancharla was appointed as Director on 14 Aug 2025.
Frequently asked questions
Magnifiq Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in paper and paper products, within the paper industry. It was incorporated on 04 July 2023 (3+ years old) and is registered under CIN U21001TS2023PTC174599.
Magnifiq Pharma has 3 current directors:
- Parvatham Anjamma - Director
- Venkat Sainadh Reddy Parvatham - Director
- Hari Hara Satish Kancharla - Director
The latest financial statements of Magnifiq Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Magnifiq Pharma is U21001TS2023PTC174599. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Magnifiq Pharma was incorporated on 04 July 2023, making it 3+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Magnifiq Pharma by revenue are G. A. Exports Private Limited, Worels Pharma Private Limited, Kar Auto Private Limited, Velisca Healthcare Private Limited, Maxaroma Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Hari Hara Satish Kancharla was appointed as Director on 14 Aug 2025. Parvatham Anjamma was appointed as Director on 04 Jul 2023. Venkat Sainadh Reddy Parvatham was appointed as Director on 04 Jul 2023.
The registered office of Magnifiq Pharma is at Flat 704 Block F Vertex Sadguru Krupa Apartments Bridavan Colony, Nizampet X Road, Hyderabad, Telangana, India – 500072.
Magnifiq Pharma operates in the paper industry, in the paper and paper products segment.
Magnifiq Pharma has open charges of ₹1 Cr and no satisfied charges on record as per latest MCA filings.
Magnifiq Pharma can be reached at its registered office: Flat 704 Block F Vertex Sadguru Krupa Apartments Bridavan Colony, Nizampet X Road, Hyderabad, Telangana, India – 500072.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
